CDK4/6 inhibition triggers anti-tumor immunity

Cyclin-dependent kinases 4 and 6 (CDK4/6) are fundamental drivers of the cell cycle and are required for the initiation and progression of various malignancies(1,2). Pharmacologic inhibitors of CDK4/6 have shown significant activity against several solid tumors(3,4). Their primary mechanism of actio...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Shom, DeCristo, Molly J., Watt, April C., BrinJones, Haley, Sceneay, Jaclyn, Li, Ben B., Khan, Naveed, Ubellacker, Jessalyn M., Xie, Shaozhen, Metzger-Filho, Otto, Hoog, Jeremy, Ellis, Matthew J., Ma, Cynthia, Ramm, Susanne, Krop, Ian E., Winer, Eric P., Roberts, Thomas M., Kim, Hye-Jung, McAllister, Sandra S., Zhao, Jean J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570667/
https://www.ncbi.nlm.nih.gov/pubmed/28813415
http://dx.doi.org/10.1038/nature23465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570667/
https://www.ncbi.nlm.nih.gov/pubmed/28813415
http://dx.doi.org/10.1038/nature23465

Ejemplares similares